Articles with public access mandates - Ben MurrellLearn more
Not available anywhere: 1
Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir‐containing regimens
N Bhardwaj, M Ragonnet‐Cronin, B Murrell, K Chodavarapu, R Martin, ...
Journal of viral hepatitis 25 (4), 344-353, 2018
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Available somewhere: 109
RDP4: Detection and analysis of recombination patterns in virus genomes
DP Martin, B Murrell, M Golden, A Khoosal, B Muhire
Virus evolution 1 (1), vev003, 2015
Mandates: US National Institutes of Health, National Research Foundation, South Africa
Detecting individual sites subject to episodic diversifying selection
B Murrell, JO Wertheim, S Moola, T Weighill, K Scheffler, ...
PLoS genetics 8 (7), e1002764, 2012
Mandates: US National Institutes of Health
FUBAR: a fast, unconstrained bayesian approximation for inferring selection
B Murrell, S Moola, A Mabona, T Weighill, D Sheward, ...
Molecular biology and evolution 30 (5), 1196-1205, 2013
Mandates: US National Institutes of Health
Less is more: an adaptive branch-site random effects model for efficient detection of episodic diversifying selection
MD Smith, JO Wertheim, S Weaver, B Murrell, K Scheffler, ...
Molecular biology and evolution 32 (5), 1342-1353, 2015
Mandates: US National Institutes of Health, National Research Foundation, South Africa
RELAX: detecting relaxed selection in a phylogenetic framework
JO Wertheim, B Murrell, MD Smith, SL Kosakovsky Pond, K Scheffler
Molecular biology and evolution 32 (3), 820-832, 2015
Mandates: US National Institutes of Health, National Research Foundation, South Africa
Gene-wide identification of episodic selection
B Murrell, S Weaver, MD Smith, JO Wertheim, S Murrell, A Aylward, ...
Molecular biology and evolution 32 (5), 1365-1371, 2015
Mandates: US National Institutes of Health
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
M Caskey, T Schoofs, H Gruell, A Settler, T Karagounis, EF Kreider, ...
Nature medicine 23 (2), 185-191, 2017
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, Howard …
A random effects branch-site model for detecting episodic diversifying selection
SL Kosakovsky Pond, B Murrell, M Fourment, SDW Frost, W Delport, ...
Molecular biology and evolution 28 (11), 3033-3043, 2011
Mandates: US National Institutes of Health
HyPhy 2.5—a customizable platform for evolutionary hypothesis testing using phylogenies
SL Kosakovsky Pond, AFY Poon, R Velazquez, S Weaver, NL Hepler, ...
Molecular biology and evolution 37 (1), 295-299, 2020
Mandates: US National Institutes of Health, UK Engineering and Physical Sciences …
RDP5: a computer program for analyzing recombination in, and removing signals of recombination from, nucleotide sequence datasets
DP Martin, A Varsani, P Roumagnac, G Botha, S Maslamoney, T Schwab, ...
Virus Evolution 7 (1), veaa087, 2021
Mandates: Swedish Research Council, National Research Foundation, South Africa
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ...
Nature communications 11 (1), 5064, 2020
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council, European …
Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance
KM Cirelli, DG Carnathan, B Nogal, JT Martin, OL Rodriguez, ...
Cell 177 (5), 1153-1171. e28, 2019
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
L Hanke, L Vidakovics Perez, DJ Sheward, H Das, T Schulte, ...
Nature communications 11 (1), 4420, 2020
Mandates: Swedish Research Council, European Commission
Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort
E Landais, X Huang, C Havenar-Daughton, B Murrell, MA Price, ...
PLoS pathogens 12 (1), e1005369, 2016
Mandates: US National Institutes of Health
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
DP Martin, S Weaver, H Tegally, JE San, SD Shank, E Wilkinson, ...
Cell 184 (20), 5189-5200. e7, 2021
Mandates: US National Science Foundation, US National Institutes of Health, UK Medical …
Social and genetic networks of HIV-1 transmission in New York City
JO Wertheim, SL Kosakovsky Pond, LA Forgione, SR Mehta, B Murrell, ...
PLoS pathogens 13 (1), e1006000, 2017
Mandates: US National Institutes of Health
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
TF Custódio, H Das, DJ Sheward, L Hanke, S Pazicky, J Pieprzyk, ...
Nature communications 11 (1), 5588, 2020
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council, European …
Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers
MG Pauthner, JP Nkolola, C Havenar-Daughton, B Murrell, SM Reiss, ...
Immunity 50 (1), 241-252. e6, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, Canadian …
Early antibody lineage diversification and independent limb maturation lead to broad HIV-1 neutralization targeting the Env high-mannose patch
DT MacLeod, NM Choi, B Briney, F Garces, LS Ver, E Landais, B Murrell, ...
Immunity 44 (5), 1215-1226, 2016
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health …
Publication and funding information is determined automatically by a computer program